Question · asked by 1 review
Combined immune checkpoint inhibitors (ICIs) vs chemotherapy alone: Health‐related quality of life
- Population
- People with advanced non‐small cell lung cancer
- Intervention
- Combined immune checkpoint inhibitors (ICIs)
- Comparison
- chemotherapy alone
- Outcome
- Health‐related quality of life
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Combined immune checkpoint inhibitors (ICIs) vs chemotherapy HRQoL · people with advanced non‐small cell lung cancer The review found no eligible studies for this question. Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or… (2021) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people… 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.